Suitability of Surgical Tumor Tissues, Biopsy, or Cytology Samples for Epidermal Growth Factor Receptor Mutation Testing in Non–Small Cell Lung Carcinoma Based on Chinese Population-Reference-Cited by-同舟云学术

Suitability of Surgical Tumor Tissues, Biopsy, or Cytology Samples for Epidermal Growth Factor Receptor Mutation Testing in Non–Small Cell Lung Carcinoma Based on Chinese Population

Published:2014-12 Issue:6 Volume:7 Page:795-799
ISSN:1936-5233
Container-title:Translational Oncology
language:en
Short-container-title:Translational Oncology

Author:

Han Xiaohong,Zhang Zhishang,Wu Di,Shen Yinchen,Wang Shuai,Wang Lin,Liu Yutao,Yang Sheng,Hu Xingsheng,Feng Yun,Sun Yan,Shi Yuankai

Funder

Chinese National Major Project for New Drug Innovation

Chinese National High Technology Research and Development Program of China (863 Program)

National Natural Science Foundation of China

Major Project of Beijing Municipal Science and Technology Commission

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference36 articles.

1. ESMO Guidelines Working Group. Metastatic non–small-cell lung cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up;D’Addario;Ann Oncol,2010

2. American Society of Clinical Oncology treatment of unresectable non–small cell lung cancer guideline: update 2003;Pfister;J Clin Oncol,2004

3. First-SIGNAL: first-line single-agent iressa versus gemcitabine and cisplatin trial in never-smokers with adenocarcinoma of the lung;Han;J Clin Oncol,2012

4. Icotinib versus gefitinib in previously treated advanced non–small-cell lung cancer (ICOGEN): a randomised, double-blind phase 3 non-inferiority trial;Shi;Lancet Oncol,2013

5. Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Worldwide Prevalence of Epidermal Growth Factor Receptor Mutations in Non-Small Cell Lung Cancer: A Meta-Analysis;Molecular Diagnosis & Therapy;2021-11-23

2. High-resolution computed tomography findings independently predict epidermal growth factor receptor mutation status in ground-glass nodular lung adenocarcinoma;World Journal of Clinical Cases;2021-11-16

3. Driver and novel genes correlated with metastasis of non-small cell lung cancer: A comprehensive analysis;Pathology - Research and Practice;2021-08

4. The expression of circulating miR-504 in plasma is associated with EGFR mutation status in non-small-cell lung carcinoma patients;Cellular and Molecular Life Sciences;2019-04-05

5. Histologic grade with thyroid transcription factor 1 and sample type serve as independent factors for the incidence of EGFR mutations in Non-small cell lung cancer;Eurasian Journal of Medicine and Oncology;2019